These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 12374680)

  • 1. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma.
    Ikeguchi M; Ueda T; Sakatani T; Hirooka Y; Kaibara N
    Diagn Mol Pathol; 2002 Mar; 11(1):33-40. PubMed ID: 11854600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
    Ikeguchi M; Hirooka Y
    Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
    Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST; Gui SQ; Lin MS
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
    J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
    Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
    Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin promotes cell proliferation in human hepatocellular carcinoma.
    Ito T; Shiraki K; Sugimoto K; Yamanaka T; Fujikawa K; Ito M; Takase K; Moriyama M; Kawano H; Hayashida M; Nakano T; Suzuki A
    Hepatology; 2000 May; 31(5):1080-5. PubMed ID: 10796883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of survivin on cell proliferation and apoptosis in gastric cancer.
    Wakana Y; Kasuya K; Katayanagi S; Tsuchida A; Aoki T; Koyanagi Y; Ishii H; Ebihara Y
    Oncol Rep; 2002; 9(6):1213-8. PubMed ID: 12375022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M; Kaibara N
    Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of inducible nitric oxide synthase during cisplatin-based chemotherapy for gastric cancer.
    Ikeguchi M; Ueta T; Kaibara N
    In Vivo; 2002; 16(3):185-90. PubMed ID: 12182114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.
    Cho S; Lee JH; Cho SB; Yoon KW; Park SY; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    Pathol Int; 2010 Mar; 60(3):203-11. PubMed ID: 20403046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
    Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
    BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
    Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.
    Kishi H; Igawa M; Kikuno N; Yoshino T; Urakami S; Shiina H
    J Urol; 2004 May; 171(5):1855-60. PubMed ID: 15076293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?
    Moon WS; Tarnawski AS
    Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
    Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
    Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.